ClinicalTrialsFinder

ER-Negative Breast Cancer Clinical Trials in Durham, North Carolina

1 recruitingDurham, North Carolina

Showing 1–1 of 1 trials

Recruiting
Phase 2

DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs

Breast CancerBreast Cancer FemaleHER2-Negative Breast Carcinoma+4 more
Sarah Sammons, MD58 enrolled3 locationsNCT06176261